Recent advances in the neurobiology of anxiety disorders: Implications for novel therapeutics
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Anxiety disorders are a highly prevalent and disabling class of psychiatric disorders. This review focuses on new directions in neurobiological research and implications for the development of novel psychopharmacological treatments. Neuroanatomical and neuroimaging research in anxiety disorders has centered on the role of the amygdala, reciprocal connections between the amygdala and the prefrontal cortex, and, most recently, alterations in interoceptive processing by the anterior insula. Anxiety disorders are characterized by alterations in a diverse range of neurochemical systems, suggesting ample novel targets for drug therapies. Corticotropin‐releasing factor (CRF) concentrations are elevated in a subset of anxiety disorders, which suggests the potential utility of CRF receptor antagonists. Pharmacological blockade of the memory‐enhancing effects of stress hormones such as glucocorticoids and noradrenaline holds promise as a preventative approach for trauma‐related anxiety. The glutamatergic system has been largely overlooked as a potential pharmacological target, although convergent preclinical, neuroimaging, and early clinical findings suggest that glutamate receptor antagonists may have potent anxiolytic effects. Glutamatergic receptor agonists (e.g., D‐cycloserine) also have an emerging role in the treatment of anxiety as facilitators of fear extinction during concurrent behavioral interventions. The neuropeptides substance P, neuropeptide Y, oxytocin, orexin, and galanin are each implicated in anxiety pathways, and neuropeptide analogs or antagonists show early promise as anxiolytics in preclinical and/or clinical research. Each of these active areas of research holds promise for expanding and improving evidence‐based treatment options for individuals suffering with clinical anxiety. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI
Phan, K. L., Wager, T., Taylor, S. F., & Liberzon, I. (2002) · NeuroImage · doi:10.1006/nimg.2002.1087 · Cited by 3,502
Neural systems supporting interoceptive awareness
Critchley, H. D., Wiens, S., Rotshtein, P., Öhman, A., & Dolan, R. J. (2004) · Nature Neuroscience · doi:10.1038/nn1176 · Cited by 3,406 · cited 1×
“Although the bulk of anxiety disorder research to date has focused on the amygdala and its reciprocal connections to the prefrontal cortex, an emerging region of interest is the insula, known primarily for its central role in interoception [Critchley et al., 2004].”
BackgroundContributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior
Phelps, E. A., & LeDoux, J. E. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.025 · Cited by 3,203
Miller, G. E., Chen, E., & Zhou, E. S. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.1.25 · Cited by 2,467 · cited 1×
“…CRF in the cerebrospinal fluid [CSF; Bremner et al., 1997; Baker et al., 1999; Sautter et al., 2003], hypersuppression of cortisol in low dose (0.50 or 0.25 mg) dexamethasone-suppression tests [de Kloet et al., 2006], and, in a subset of studies, low 24-hr cortisol output [Miller et al., 2007].”
BackgroundInfluentialThe endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans
Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B., & Meyer-Lindenberg, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3984-05.2005 · Cited by 1,639
Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.195 · Cited by 1,605
Self-citation
Cited by
Joëls, M., & Baram, T. Z. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2632 · Cited by 1,521
Oxidative Stress and Anxiety: Relationship and Cellular Pathways
Bouayed, J., Rammal, H., & Soulimani, R. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.2.7944 · Cited by 517
Animal models of anxiety disorders and stress
Campos, A. C., Fogaca, M. V., Aguiar, D. C., & Guimaraes, F. S. (2013) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2013-1139 · Cited by 471
Dynorphin, stress, and depression
Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465
Exploring the convergence of posttraumatic stress disorder and mild traumatic brain injury
Stein, M. B., & McAllister, T. W. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08101604 · Cited by 391
The CRF system, stress, depression and anxiety—insights from human genetic studies
Binder, E. B., & Nemeroff, C. B. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.141 · Cited by 379
Radley, J., Morilak, D., Viau, V., & Campeau, S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.06.018 · Cited by 339
Wohleb, E. S., McKim, D. B., Shea, D. T., Powell, N. D., Tarr, A. J., Sheridan, J. F., & Godbout, J. P. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.11.029 · Cited by 300
Stress, anxiety, and dendritic spines: What are the connections?
Leuner, B., & Shors, T. J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.021 · Cited by 284
Grillon, C., Pine, D. S., Lissek, S., Rabin, S., Bonne, O., & Vythilingam, M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.028 · Cited by 272
Behavioral effects of neuropeptides in rodent models of depression and anxiety
Rotzinger, S., Lovejoy, D. A., & Tan, L. A. (2010) · Peptides · doi:10.1016/j.peptides.2009.12.015 · Cited by 211
Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
Krystal, J. H., Mathew, S. J., DʼSouza, D. C., Garakani, A., Gunduz-Bruce, H., & Charney, D. S. (2010) · CNS Drugs · doi:10.2165/11533230-000000000-00000 · Cited by 180
Self-citationCurrent status of brain imaging in anxiety disorders
Damsa, C., Kosel, M., & Moussally, J. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328319bd10 · Cited by 160
Functional autonomic nervous system profile in children with autism spectrum disorder
Kushki, A., Brian, J., Dupuis, A., & Anagnostou, E. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-39 · Cited by 145
“From a neurobiological perspective, both ASD and anxiety disorders have been associated with differences in central structures involved in emotional processing (such as the amygdala, anterior cingulate cortex, prefrontal cortex, and the insular cortex) [64,65].”
BackgroundDoes Anxiety Affect Risk of Dementia? Findings From the Caerphilly Prospective Study
Gallacher, J., Bayer, A., Fish, M., Pickering, J., Pedro, S., Dunstan, F., Ebrahim, S., & Ben-Shlomo, Y. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181a6177c · Cited by 137
“Other candidate mechanisms involve the hypothalamic-pituitary-adrenal axis and various neuropeptides (37).”
BackgroundPhan, K. L., Coccaro, E. F., Angstadt, M., Kreger, K. J., Mayberg, H. S., Liberzon, I., & Stein, M. B. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.003 · Cited by 114
“Given its central role in the pathophysiology of anxiety disorders (9), the amygdala in particular is thought to be a key target of anxiolytic interventions (10).”
BackgroundNinan, I. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07430.x · Cited by 110
Data-Driven Subgroups in Depression Derived from Directed Functional Connectivity Paths at Rest
Price, R. B., Gates, K., Kraynak, T. E., Thase, M. E., & Siegle, G. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.97 · Cited by 98
Self-citationAmygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder
Faria, V., Appel, L., Åhs, F., Linnman, C., Pissiota, A., Frans, Ö., Bani, M., Bettica, P., Pich, E. M., Jacobsson, E., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.72 · Cited by 73
Lenze, E. J., & Wetherell, J. L. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2074 · Cited by 57
CRHR1 links peripuberty stress with deficits in social and stress-coping behaviors
Veenit, V., Riccio, O., & Sandi, C. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.02.015 · Cited by 45
Hoppe, J. M., Frick, A., Åhs, F., Linnman, C., Appel, L., Jonasson, M., Lubberink, M., Långström, B., Frans, Ö., von Knorring, L., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0163-1 · Cited by 18
Benzodiazepines Dependence: Addiction to Legally Prescribed Substances
S. Anna Gandra, S., D Almeida, A. L., & M. Teixeira, Z. (2019) · Journal of Forensic Psychology · doi:10.35248/2475-319x.19.4.149 · Cited by 4
“Anxiety disorders are a class of psychiatric disorders that are highly prevalent and disabling [13-15,33].”
Background
Metadata
- Authors
- Mathew, S. J., Price, R. B., & Charney, D. S.
- Venue
- American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Publisher
- Wiley
- Published
- 2008-04-22
- Volume
- 148C
- Issue
- 2
- Pages
- 89-98
- ISSN
- 1552-4868 (ISSN-L)
- 1552-4876
- OpenAlex
- W2088632365
- Cited by
- 168
- References
- 50
- FWCI
- 32.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.